Process for the preparation of substituted oxiranes and triazoles
US-9981931-B2 · May 29, 2018 · US
US10981883B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10981883-B2 |
| Application number | US-201916694296-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 25, 2019 |
| Priority date | Jan 9, 2013 |
| Publication date | Apr 20, 2021 |
| Grant date | Apr 20, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a process for the preparation of the compounds II from the respective oxo compounds. Furthermore, the invention relates to a process for the preparation of triazole compounds from oxiranes II.
Opening claim text (preview).
The invention claimed is: 1. A process for the preparation of a triazole compound of formula I comprising (iia) reacting a compound of formula II with 1H-1,2,4-triazole and an inorganic base, wherein the amount of the inorganic base is less than 1 equivalent of said base per 1 equivalent of compound II, resulting in the compound of formula I, wherein R 1 is selected from C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 8 -cycloalkyl, C 3 -C 8 -cycloalkyl-C 1 -C 6 -alkyl, phenyl, phenyl-C 1 -C 4 -alkyl, phenyl-C 2 -C 4 -alkenyl or phenyl-C 1 -C 4 -alkynyl; wherein the aliphatic moieties of R 1 are not further substituted or do carry one, two, three or up to the maximum possible number of identical or different groups R 12a which independently are selected from: R 12a halogen, OH, CN, nitro, C 1 -C 4 -alkoxy, C 3 -C 8 -cycloalkyl, C 3 -C 8 -halocycloalkyl and C 1 -C 4 -halogenalkoxy; wherein the cycloalkyl and/or phenyl moieties of R 1 are not further substituted or do carry one, two, three, four, five or up to the maximum number of identical or different groups R 12b which independently are selected from: R 12b halogen, OH, CN, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -halogenalkyl, C 3 -C 8 -cycloalkyl, C 3 -C 8 -halocycloalkyl and C 1 -C 4 -halogenalkoxy R 3 is independently selected from halogen, CN, NO 2 , OH, SH, C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 8 -cycloalkyl, C 3 -C 8 -cycloalkyloxy, NH 2 , NH(C 1 -C 4 -alkyl), N(C 1 -C 4 -alkyl) 2 , NH(C 3 -C 6 -cycloalkyl), N(C 3 -C 6 -cycloalkyl) 2 , S(O) p (C 1 -C 4 -alkyl), C(═O)(C 1 -C 4 -alkyl), C(═O)(OH), C(═O)(O—C 1 -C 4 -alkyl), C(═O)(NH(C 1 -C 4 -alkyl)), C(═O)(N(C 1 -C 4 -alkyl) 2 ), C(═O)(NH(C 3 -C 6 -cycloalkyl)) and C(═O)—(N(C 3 -C 6 -cycloalkyl) 2 ); wherein p is 0, 1 or 2; and wherein each of R 3 is unsubstituted or further substituted by one, two, three or four R 3 ; wherein R 3a is independently selected from halogen, CN, NO 2 , OH, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 3 -C 8 -cycloalkyl, C 3 -C 8 -halocycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkoxy; R 4 is independently selected from the substituents as defined for R 3 , wherein said R 4 are unsubstituted or further substituted by one, two, three or four R 4a , wherein each R 4a is independently selected from the substituents as defined for R 3a ; n is 0, 1, 2, 3 or 4; and m is 0, 1, 2, 3, 4 or 5, wherein the product resulting from step (iia) is crystallized from toluene and/or an aliphatic alcohol. 2. The process of claim 1 , wherein the aliphatic alcohol is selected from methanol, ethanol, n-propanol, iso-propanol, n-butanol, isobutanol or any mixture thereof. 3. The process of claim 1 , wherein the base used in step (iia) is selected from NaOH, KOH, Na 2 CO 3 and K 2 CO 3 . 4. The process of claim 1 , wherein the base used in step (iia) is selected from NaOH and KOH. 5. The process of claim 1 , wherein the amount of base used in step (iia) is equal to or less than 0.6 equivalents per 1 equivalent of compound II.
Crystalline forms, e.g. polymorphs · CPC title
1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles · CPC title
1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles · CPC title
1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles · CPC title
Oxiranylmethyl ethers of compounds having one hydroxy group bound to a six-membered aromatic ring, the oxiranylmethyl radical not being further substituted, i.e. [IMAGE cpc-sch-C07D-1030.gif] · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.